Page last updated: 2024-10-25

deferoxamine and Blast Crisis

deferoxamine has been researched along with Blast Crisis in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Blast Crisis: An advanced phase of chronic myelogenous leukemia, characterized by a rapid increase in the proportion of immature white blood cells (blasts) in the blood and bone marrow to greater than 30%.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dezza, L1
Cazzola, M1
Danova, M1
Carlo-Stella, C1
Bergamaschi, G1
Brugnatelli, S1
Invernizzi, R1
Mazzini, G1
Riccardi, A1
Ascari, E1

Other Studies

1 other study available for deferoxamine and Blast Crisis

ArticleYear
Effects of desferrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies.
    Leukemia, 1989, Volume: 3, Issue:2

    Topics: Anemia, Refractory, with Excess of Blasts; Blast Crisis; Cell Division; Colony-Forming Units Assay;

1989